Influenza Other Respir Viruses

Excess All-Cause Mortality by Age and Gender During the COVID-19 Pandemic in the Federation of Bosnia and Herzegovina, Bosnia and Herzegovina: 2020-2022.

Cilović-Lagarija Š, Rantzau JTM, Skočibušić S, ..., Nielsen J, Jorgensen P

Influenza Other Respir Viruses 19 (3) e70086 [2025-03-00; online 2025-02-27]

Category: Public Health Type: Journal article

Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024.

Antunes L, Rojas-Castro M, Lozano M, ..., Rose AMC, VEBIS SARI VE network team

Influenza Other Respir Viruses 19 (3) e70081 [2025-03-00; online 2025-03-10]

Category: Vaccines Type: Journal article

Registry-Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021-2024.

Seppälä E, Bøås H, Dahl J, ..., Kløvstad H, Paulsen TH

Influenza Other Respir Viruses 19 (2) e70080 [2025-02-00; online 2025-02-14]

Category: Other Type: Journal article

Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023-1 March 2024.

Merdrignac L, Laniece Delaunay C, Verdasca N, ..., Kissling E, VEBIS Primary Care Vaccine Effectiveness Group

Influenza Other Respir Viruses 18 (11) e70009 [2024-11-00; online 2024-11-13]

Category: Public Health Category: Vaccines Type: Journal article

Early COVID-19 XBB.1.5 Vaccine Effectiveness Against Hospitalisation Among Adults Targeted for Vaccination, VEBIS Hospital Network, Europe, October 2023-January 2024.

Antunes L, Mazagatos C, Martínez-Baz I, ..., Rose AMC, European Hospital Vaccine Effectiveness Group

Influenza Other Respir Viruses 18 (8) e13360 [2024-08-00; online 2024-08-15]

Category: Vaccines Type: Journal article

Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study.

Monge S, Humphreys J, Nicolay N, ..., Nunes B, VEBIS‐EHR Working Group

Influenza Other Respir Viruses 18 (4) e13292 [2024-04-00; online 2024-04-24]

Category: Vaccines Type: Journal article

Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022.

Kislaya I, Sentís A, Starrfelt J, ..., Monge S, VEBIS-Lot4 working group

Influenza Other Respir Viruses 17 (11) e13195 [2023-11-00; online 2023-11-29]

Category: Public Health Category: Vaccines Type: Journal article

Hospital bed occupancy for COVID-19 or with SARS-CoV-2 infection in a Swedish county during the omicron wave.

Spreco A, Andersson C, Sjödahl R, Dahlström Ö, Timpka T

Influenza Other Respir Viruses - (-) - [2022-06-05; online 2022-06-05]

Category: Health Category: Omicron VoC Type: Journal article

Severe acute respiratory syndrome coronavirus 2 can be detected in exhaled aerosol sampled during a few minutes of breathing or coughing.

Viklund E, Kokelj S, Larsson P, ..., Westin J, Olin AC

Influenza Other Respir Viruses 16 (3) 402-410 [2022-05-00; online 2022-01-17]

Category: Health Topics: Register-based research Type: Journal article

Establishing a COVID-19 pandemic severity assessment surveillance system in Ireland.

Domegan L, Garvey P, McEnery M, ..., Cuddihy J, O'Donnell J

Influenza Other Respir Viruses - (-) - [2021-10-05; online 2021-10-05]

Category: Health Type: Journal article